BB Biotech (Germany) Today
| BBZA Stock | 40.55 0.10 0.25% |
PerformanceModest
| Odds Of DistressQuite High
|
BB Biotech is trading at 40.55 as of the 18th of February 2025, a 0.25 percent decrease since the beginning of the trading day. The stock's lowest day price was 39.6. BB Biotech has more than 61 % chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 26th of December 2023 and ending today, the 18th of February 2025. Click here to learn more.
Moving together with BBZA Stock
Moving against BBZA Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
BBZA Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. BB Biotech's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding BB Biotech or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
BB Biotech AG (BBZA) is traded on XETRA Stock Exchange in Germany and employs 10 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.16 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BB Biotech's market, we take the total number of its shares issued and multiply it by BB Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. BB Biotech AG operates under Healthcare sector and is part of Biotechnology industry. The entity has 54.85 M outstanding shares.
BB Biotech generates negative cash flow from operations
Check BB Biotech Probability Of Bankruptcy
Ownership AllocationBB Biotech AG secures a total of 54.85 Million outstanding shares. Roughly 90.48 % of BB Biotech outstanding shares are held by general public with 1.7 percent owned by insiders and only 7.82 (percent) by institutions. Please note that no matter how many assets the company retains, if the real value of the entity is less than the current market value, you may not be able to make money on it.
Check BBZA Ownership Details
BB Biotech AG Risk Profiles
Although BB Biotech's alpha and beta are two of the key measurements used to evaluate BB Biotech's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.9959 | |||
| Standard Deviation | 1.33 | |||
| Variance | 1.76 | |||
| Risk Adjusted Performance | (0.02) |
BBZA Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in BB Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Bollinger Bands Now
Bollinger BandsUse Bollinger Bands indicator to analyze target price for a given investing horizon |
| All Next | Launch Module |
Other Information on Investing in BBZA Stock
BB Biotech financial ratios help investors to determine whether BBZA Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BBZA with respect to the benefits of owning BB Biotech security.